It seems to me that taking these drugs off the market will cost them more in
the long run, because families who are caring for their relatives are able
to cope better when their loved one is more cognizant.   The result of
limiting or stopping these drugs will probably be institutionalizing people
sooner, costing more money for their care ultimately.